Page last updated: 2024-08-16

temozolomide and rolipram

temozolomide has been researched along with rolipram in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Goldhoff, P; Hope, A; Jackson, E; Limbrick, DD; Perry, A; Piwnica-Worms, D; Rubin, JB; Warrington, NM; Woerner, BM	1
Chen, TC; Cho, HY; Fu, J; Hofman, FM; Minea, RO; Ou, M; Schönthal, AH; Stathopoulos, A; Swenson, SD; Tang, L; Thein, TZ; Wang, W	1

Other Studies

2 other study(ies) available for temozolomide and rolipram

Article	Year
Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-01, Volume: 14, Issue:23 Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cyclic Nucleotide Phosphodiesterases, Type 4; Dacarbazine; Female; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Phosphodiesterase Inhibitors; Rolipram; Temozolomide; Xenograft Model Antitumor Assays	2008
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate. Autophagy, 2023, Volume: 19, Issue:12 Topics: Autophagy; Cell Death; Chloroquine; Glioblastoma; Glioma; Humans; Lysosomes; Monoterpenes; Rolipram; Sirolimus; Temozolomide; TOR Serine-Threonine Kinases	2023

Article

Year

Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-01, Volume: 14, Issue:23

Topics: Adolescent; Adult; Aged; Animals; Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Child; Child, Preschool; Combined Modality Therapy; Cyclic Nucleotide Phosphodiesterases, Type 4; Dacarbazine; Female; Humans; Immunohistochemistry; Male; Mice; Middle Aged; Phosphodiesterase Inhibitors; Rolipram; Temozolomide; Xenograft Model Antitumor Assays

2008

Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate.

Autophagy, 2023, Volume: 19, Issue:12

Topics: Autophagy; Cell Death; Chloroquine; Glioblastoma; Glioma; Humans; Lysosomes; Monoterpenes; Rolipram; Sirolimus; Temozolomide; TOR Serine-Threonine Kinases

2023